Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Reviews on Recent Clinical Trials|April 11, 2017
Rolapitant: An NK-1 Receptor Antagonist for the Prevention of Chemotherapy- Induced Nausea and VomitingBernardo L RapoportFrontiers in Pharmacology|February 15, 2017
Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current ManagementBernardo L RapoportCurrent Medical Research and Opinion|June 10, 2014
Efficacy of a triple antiemetic regimen with aprepitant for the prevention of chemotherapy-induced nausea and vomiting: effects of gender, age, and regionBernardo L RapoportFrontiers in Oncology|April 7, 2018
Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical PracticeRonald Anderson, Bernardo L RapoportInternational Journal of Molecular Sciences|March 1, 2019
Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and RadiotherapyBernardo L Rapoport, Ronald AndersonChemotherapy|February 28, 2008
Malaria parasitemia associated with febrile neutropenia in African patients undergoing chemotherapy for haematological malignancies. A report of three patientsBernardo L Rapoport, Almarie UysFuture Oncology (London, England)|February 5, 2016
Rolapitant for the treatment of chemotherapy-induced nausea and vomiting: a review of the clinical evidenceMartin R Chasen, Bernardo L RapoportCurrent Opinion in Supportive and Palliative Care|April 8, 2016
Current trends in the management of anaemia in solid tumours and haematological malignanciesRonwyn van Eeden, Bernardo L RapoportSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 16, 2004
Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index scoreAlmarie Uys, Bernardo L Rapoport, Ronald AndersonFuture Oncology (London, England)|November 14, 2017
Neurokinin 1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitantBernardo L Rapoport, Karin Jordan, Cindy WeinsteinPageof 6